CSB

Stanford School of Medicine

Chemical & Systems Biology

 
 

Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts.

Posted by CSB Department on September 14, 2004

Tanaka M, Terry RD, Mokhtari GK, Inagaki K, Koyanagi T, Kofidis T, Mochly-Rosen D, Robbins RC. (2004) Circulation. 2004 Sep 14;110(11 Suppl 1):II194-9. [PubMed]